| Medtronic launches U.S. blood pressure trial - Mass Device |
|
|
Mass Device Medtronic enrolls the first patient in its US trial of renal denervation as a treatment for high blood pressure, playing catch-up with cross-town rival St. Jude. Medtronic (NYSE:MDT) launched US trials of its Simplicity renal denervation system for |